Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Completed 155Terminated 49Recruiting 34Unknown 27Active not recruiting 23Not yet recruiting 6Withdrawn 5Enrolling by invitation 2Available 2Suspended 1No longer available 1

Sponsor Class

OTHER 89NIH 5INDUSTRY 5NETWORK 2

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

CNS 5Thoracic 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Neoplasms 83Carcinoma, Non-Small-Cell Lung 79Breast Neoplasms 71Leukemia, Myeloid, Acute 39Recurrence 36Colorectal Neoplasms 36Prostatic Neoplasms 34Neoplasm Metastasis 30Multiple Myeloma 27Pancreatic Neoplasms 25Melanoma 25Lymphoma 25Lymphoma, Non-Hodgkin 24Lung Neoplasms 23Leukemia, Lymphocytic, Chronic, B-Cell 23Ovarian Neoplasms 22Lymphoma, Follicular 22Carcinoma, Hepatocellular 22Carcinoma, Renal Cell 21Stomach Neoplasms 19Squamous Cell Carcinoma of Head and Neck 19Lymphoma, Large B-Cell, Diffuse 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Myelodysplastic Syndromes 18Urinary Bladder Neoplasms 17Leukemia 17Head and Neck Neoplasms 17Hematologic Neoplasms 14Carcinoma 13Uterine Cervical Neoplasms 12

Interventions

Tf-CRM107 1Metformin 1Mebendazole 1Doxycycline 1Corticotropin-Releasing Hormone 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Withdrawn × INDUSTRY × Brain Neoplasms × Clear all
NCT06075615 2025-02-07

A Study to Learn About Dacomitnib in Patients With Non-small Cell Lung Cancer Which Has Spread to the Brain.

Pfizer

Withdrawn
CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT02201381 2022-07-18

METRICS

Health Clinics Limited

Phase 3 Withdrawn
BreastCNSGastrointestinalGynecologic

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

NCT00797940 2012-12-03

CLARITY-1

Protox Inc.

Phase 2 Withdrawn
CNS

Brain Neoplasms, Glioblastoma, Glioma

NCT00083447 2009-01-07

Study of Therapy With TransMIDâ„¢ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme

Xenova Biomedix

Phase 3 Withdrawn
323 enrolled
CNS

Brain Neoplasms, Glioblastoma

NCT00226668 2008-01-03

XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema

Celtic Pharma Development Services

Phase 3 Withdrawn
120 enrolled
CNS

Astrocytoma, Brain Edema, Brain Neoplasms, Edema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡